{"DataElement":{"publicId":"2480790","version":"2","preferredName":"Aberrant Crypt Foci Preparation Type","preferredDefinition":"The methods used for preparing the aberrant crypt foci (ACF) for examination.","longName":"ACF_PREP_TP","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2480787","version":"1","preferredName":"Aberrant Crypt Focus Preparation","preferredDefinition":"Information pertaining to the types of ACF preparations.","longName":"ACF_PREP","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2480785","version":"1","preferredName":"Aberrant Crypt Focus","preferredDefinition":"A larger than normal, microscopically elevated colonic crypt that may contain dysplastic epithelium.  It is considered as a possible precursor of colonic adenoma and carcinoma","longName":"C60536","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aberrant Crypt Focus","conceptCode":"C60536","definition":"A larger than normal, microscopically elevated colonic crypt that may contain dysplastic epithelium.  It is considered as a possible precursor of colonic adenoma and carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"134887C3-A102-0A6B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-08","modifiedBy":"ONEDATA","dateModified":"2006-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2480060","version":"1","preferredName":"Preparation","preferredDefinition":"The act or process of making something ready; also a medication made ready for administration; also an anatomic or pathologic specimen made ready and preserved for study.","longName":"C25625","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preparation","conceptCode":"C25625","definition":"The act or process of making something ready.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"12CFCC9F-9A9F-6965-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-02","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-02","modifiedBy":"ONEDATA","dateModified":"2006-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"134887C3-A110-0A6B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2480788","version":"2","preferredName":"Aberrant Crypt Foci Preparation Type","preferredDefinition":"The Aberrant Crypt Foci preparation types.","longName":"ACF_PREP_TP","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Polyethylene glycol","valueDescription":"Polyethylene glycol","ValueMeaning":{"publicId":"2579249","version":"1","preferredName":"Polyethylene glycol","longName":"2579249","preferredDefinition":"A polymer made by joining molecules of ethylene oxide and water together in a repeating pattern. Polyethylene glycol can be a liquid or a waxy solid. In medicine, forms of polyethylene glycol can be used in ointments, in drugs or substances to make them stay in the body longer, or in laxatives.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polyethylene Glycol","conceptCode":"C762","definition":"A polymer made by joining molecules of ethylene oxide and water together in a repeating pattern. Polyethylene glycol can be a liquid or a waxy solid. In medicine, forms of polyethylene glycol can be used in ointments, in drugs or substances to make them stay in the body longer, or in laxatives.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-029E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-08","modifiedBy":"COOPERM","dateModified":"2019-11-18","changeDescription":"Added current NCIt concept and definition. mc 11/18/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"82135F20-A379-B81D-E040-BB89AD43367D","beginDate":"2006-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-03-18","modifiedBy":"ONEDATA","dateModified":"2010-03-18","deletedIndicator":"No"},{"value":"Sodium phosphate (tablet)","valueDescription":"Sodium phosphate (tablet)","ValueMeaning":{"publicId":"2579250","version":"1","preferredName":"Sodium phosphate (tablet)","longName":"2579250","preferredDefinition":"Sodium phosphate (tablet)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-029F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-08","modifiedBy":"MAESKEB","dateModified":"2006-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"82135F20-A383-B81D-E040-BB89AD43367D","beginDate":"2006-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-03-18","modifiedBy":"ONEDATA","dateModified":"2010-03-18","deletedIndicator":"No"},{"value":"Sodium phosphate (liquid)","valueDescription":"Sodium phosphate (liquid)","ValueMeaning":{"publicId":"2579251","version":"1","preferredName":"Sodium phosphate (liquid)","longName":"2579251","preferredDefinition":"Sodium phosphate (liquid)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-02A0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-05-08","modifiedBy":"MAESKEB","dateModified":"2006-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"82135F20-A38D-B81D-E040-BB89AD43367D","beginDate":"2006-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-03-18","modifiedBy":"ONEDATA","dateModified":"2010-03-18","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"Other specify","ValueMeaning":{"publicId":"2570538","version":"1","preferredName":"Other specify","longName":"2570538","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E097-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-11-17","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12 - reversed concept order to match the semantics of this phrase which is \"other\" with \"specify\" as a qualifier/modifier - DW 12-30-2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"82135F20-A397-B81D-E040-BB89AD43367D","beginDate":"2006-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-03-18","modifiedBy":"ONEDATA","dateModified":"2010-03-18","deletedIndicator":"No"},{"value":"Reglan/Golytely/Mag. Citrate","valueDescription":"Reglan/Golytely/Mag. Citrate","ValueMeaning":{"publicId":"3027965","version":"1","preferredName":"Reglan/Golytely/Mag. Citrate","longName":"3027965","preferredDefinition":"Reglan/Golytely/Mag. Citrate","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82135F20-A341-B81D-E040-BB89AD43367D","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"82135F20-A3A1-B81D-E040-BB89AD43367D","beginDate":"2010-03-18","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-03-18","modifiedBy":"ONEDATA","dateModified":"2010-03-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82135F20-A364-B81D-E040-BB89AD43367D","latestVersionIndicator":"Yes","beginDate":"2006-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-03-18","modifiedBy":"PWEST","dateModified":"2014-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812155","version":"1","longName":"Sporadic Colorectal Neoplasia - Atrovastatin","context":"DCP"},{"publicId":"2812553","version":"1","longName":"EGF Receptor Signaling in ACF","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Type of preparation","type":"Preferred Question Text","description":"Type of preparation","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"82135F20-A3EA-B81D-E040-BB89AD43367D","latestVersionIndicator":"Yes","beginDate":"2010-03-18","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-03-18","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}